-- U.S. RESEARCH ROUNDUP-Eli Lilly, Veracyte 
-- 
-- Wed Mar 19, 2014 03:01AM EDT
-- None



March 19 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Eli Lilly And Co and Veracyte Inc, on Wednesday.

HIGHLIGHTS * Eli Lilly <LLY.N>: Jefferies raises target price to $45 [ID:nWNAB04FPZ]  * Veracyte Inc <VCYT.O>: Leerink raises price target to $23 from $21; rating outperform  Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.   * Abbott ABT.N: Jefferies cuts target price to $45; rating buy  * Abbvie Inc <ABBV.N>: Jefferies cuts target price to $60; rating buy  * Bright Horizons Family Solutions <BFAM.N>: Jefferies raises target to $45 from $43; buy * Bristol-Myers Squibb Co <BMY.N>: Jefferies raises target price to $48; rating hold  * Consolidated Water Co Ltd <CWCO.O>: Roth raises target price to $18; rating buy * Diamond Offshore Drilling <DO.N>: JP Morgan cuts target to $51 from $57; rating overweight * Discovery Laboratories Inc <DSCO.O>: Roth cuts target price to $5.50 from $6; rating buy * Eli Lilly <LLY.N>: Jefferies raises target price to $45  * Hormel Foods Corp <HRL.N>: KeyBanc raises price target to $55 from $52; rating buy * Independent Bank Group <IBTX.O>: KBW raises target to $57 from $53; rating market perform * J&J <JNJ.N>: Jefferies raises target price to $105; rating buy  * Merck <MRK.N>: Jefferies raises target price to $57; rating hold * Solarcity Corp <SCTY.O>: Roth raises target price to $80 from $65; rating neutral * Veracyte Inc <VCYT.O>: Leerink raises price target to $23 from $21; rating outperform * Weingarten Realty Investors <WRI.N>: Cowen and Company ups target to $34; outperform  * Zoetis Inc <ZTS.N: Jefferies cuts target price to $35; rating buy